Coverage of Over-the-Counter (OTC) COVID-19 Testing

Beginning January 15, 2022 the Compass Rose Health Plan will provide assistance on reimbursement of over-the-counter (OTC) COVID-19 tests that have been authorized or approved by the U.S. Food and Drug Administration (FDA).

Members and their covered dependents may receive 8 tests per 30-day period (or per calendar month). Each test is counted separately if multiple tests are sold in one package.

As guidance was just released on January 10, 2022, additional information will be forthcoming.